The Filing Desk

ASP Isotopes vs Cabot

ASP Isotopes ASPI · Cabot CBT · Diversified Chemicals

Cabot reported revenue of $3.7 billion in fiscal 2025, 156.0 times ASP Isotopes' $24 million in fiscal 2025. ASP Isotopes' revenue grew 475.5% in its latest year, and Cabot's fell 7.0%. ASP Isotopes had an operating margin of -251.2%, against 16.7% at Cabot. Free cash flow was −$47 million at ASP Isotopes and $391 million at Cabot. Their fiscal years end in different months (December 31 and September 30), so the periods don't line up exactly.

Side by side

ASP IsotopesCabot
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Sep 30, 2025
Revenue$24M$3.7B
Revenue growth475.5%−7.0%
Revenue growth a year, last 5 years—7.3%
Gross margin14.3%25.3%
Operating margin−251.2%16.7%
Net margin−670.2%8.9%
Free cash flow−$47M$391M
Free cash flow margin−198.9%10.5%
Return on capital—15.9%
Net debt to EBITDA—1.1x
Dividends and buybacks$0M$264M
Change in diluted share count49.1%−2.7%
Last close$1.74$71.92
P/E at the last close—12.6×
Insider trades, last 12 monthsbought $21,600, sold $9.4 millionsold $19.6 million
Piotroski F-score3 of 96 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ASP IsotopesCabot
Operating margin
Percent of revenue
ASP IsotopesCabot
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ASP IsotopesCabot

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the ASP Isotopes and Cabot pages.